Haemonetics 3rd Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Haemonetics (HAE) Sell-Off Overdone - Jefferies
February 5, 2019 12:40 PM ESTJefferies analyst Anthony Petrone came out to defend Haemonetics (NYSE: HAE) calling the sell-off overdone and providing a good entry point.
The high-level sticking points are: 1) implicit plasma guide for F2020; 2) pace of NexSys contracting; and 3) level of spend in Q and... More
Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below Consensus
February 5, 2019 6:11 AM ESTHaemonetics (NYSE: HAE) reported Q3 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $247 million versus the consensus estimate of $250.13 million.
Chris Simon, Haemonetics CEO, stated: Our third quarter performance met our expectations
and reinforces that our... More
